Cibelly Goulart

Sao Paulo, SP 05503900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice.

Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice.

Journal: Vaccines

Published: November 27, 2023

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.

Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.

Journal: PloS one

Published: April 23, 2023

Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate.

Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate.

Journal: Frontiers in bioengineering and biotechnology

Published: November 25, 2022

Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.

Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.

Journal: PloS one

Published: March 07, 2022

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.

Journal: Frontiers in immunology

Published: November 23, 2018

Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.

Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.

Journal: mBio

Published: October 18, 2018

Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF).

Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF).

Journal: Vaccine: X

Published: October 16, 2018

A Bivalent Recombinant Mycobacterium bovis BCG Expressing the S1 Subunit of the Pertussis Toxin Induces a Polyfunctional CD4+ T Cell Immune Response.

A Bivalent Recombinant Mycobacterium bovis BCG Expressing the S1 Subunit of the Pertussis Toxin Induces a Polyfunctional CD4+ T Cell Immune Response.

Journal: BioMed research international

Published: October 08, 2018

A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.

A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.

Journal: Clinical and vaccine immunology : CVI

Published: April 27, 2017

Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.

Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.

Journal: Vaccine

Published: November 01, 2016

New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.

New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.

Journal: Applied and environmental microbiology

Published: November 25, 2015

Current status and perspectives on protein-based pneumococcal vaccines.

Current status and perspectives on protein-based pneumococcal vaccines.

Journal: Critical reviews in microbiology

Published: July 31, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026